![](/img/cover-not-exists.png)
An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma
Sano, Renata, Krytska, Kateryna, Larmour, Colleen E., Raman, Pichai, Martinez, Daniel, Ligon, Gwenda F., Lillquist, Jay S., Cucchi, Ulisse, Orsini, Paolo, Rizzi, Simona, Pawel, Bruce R., Alvarado, DieVolume:
11
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.aau9732
Date:
March, 2019
File:
PDF, 683 KB
2019